Matches in Wikidata for { <http://www.wikidata.org/entity/Q93045695> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q93045695 description "article scientifique publié en 2019" @default.
- Q93045695 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q93045695 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q93045695 description "im Jahr 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93045695 description "scientific article published on 01 January 2019" @default.
- Q93045695 description "wetenschappelijk artikel" @default.
- Q93045695 description "наукова стаття, опублікована 1 січня 2019" @default.
- Q93045695 name "[Inhibition of Group IVA Phospholipase A2 as a Novel Therapeutic Strategy for Nonalcoholic Steatohepatitis]" @default.
- Q93045695 name "[Inhibition of Group IVA Phospholipase A2 as a Novel Therapeutic Strategy for Nonalcoholic Steatohepatitis]" @default.
- Q93045695 name "[Inhibition of Group IVA Phospholipase A2 as a Novel Therapeutic Strategy for Nonalcoholic Steatohepatitis]" @default.
- Q93045695 type Item @default.
- Q93045695 label "[Inhibition of Group IVA Phospholipase A2 as a Novel Therapeutic Strategy for Nonalcoholic Steatohepatitis]" @default.
- Q93045695 label "[Inhibition of Group IVA Phospholipase A2 as a Novel Therapeutic Strategy for Nonalcoholic Steatohepatitis]" @default.
- Q93045695 label "[Inhibition of Group IVA Phospholipase A2 as a Novel Therapeutic Strategy for Nonalcoholic Steatohepatitis]" @default.
- Q93045695 prefLabel "[Inhibition of Group IVA Phospholipase A2 as a Novel Therapeutic Strategy for Nonalcoholic Steatohepatitis]" @default.
- Q93045695 prefLabel "[Inhibition of Group IVA Phospholipase A2 as a Novel Therapeutic Strategy for Nonalcoholic Steatohepatitis]" @default.
- Q93045695 prefLabel "[Inhibition of Group IVA Phospholipase A2 as a Novel Therapeutic Strategy for Nonalcoholic Steatohepatitis]" @default.
- Q93045695 P1433 Q93045695-B52528CC-F7A4-40D5-9489-DC32F16EB8D6 @default.
- Q93045695 P1476 Q93045695-5DC84CCC-CDBE-4C5D-AB81-DE814DEE0164 @default.
- Q93045695 P2093 Q93045695-6FEDBE6E-6E38-4E30-B8F1-F6A94DEA515F @default.
- Q93045695 P2093 Q93045695-A409CAF8-C152-4619-A497-BE7B34029263 @default.
- Q93045695 P2093 Q93045695-CF6543CD-D012-4818-8028-2E8D780E1672 @default.
- Q93045695 P304 Q93045695-02ACEB6F-5B27-4CA3-B702-AFEA94F0C8C9 @default.
- Q93045695 P31 Q93045695-A03212A7-B184-4885-976D-EB63AB69AF23 @default.
- Q93045695 P356 Q93045695-7658B533-0C8A-408D-8E8D-CD856AB0B0B9 @default.
- Q93045695 P433 Q93045695-BE041120-F1FE-47B9-A7E9-C761AEAEFB86 @default.
- Q93045695 P478 Q93045695-5D1E4223-AB13-4A92-9771-67F1537E78F3 @default.
- Q93045695 P577 Q93045695-D0B02762-F2B6-461B-BB9E-A1263A378E35 @default.
- Q93045695 P698 Q93045695-5D7C67B4-D08A-444A-801C-A88FF922B4D3 @default.
- Q93045695 P356 YAKUSHI.19-00011-2 @default.
- Q93045695 P698 31474631 @default.
- Q93045695 P1433 Q15758172 @default.
- Q93045695 P1476 "[Inhibition of Group IVA Phospholipase A2 as a Novel Therapeutic Strategy for Nonalcoholic Steatohepatitis]" @default.
- Q93045695 P2093 "Eri Kawashita" @default.
- Q93045695 P2093 "Keiichi Ishihara" @default.
- Q93045695 P2093 "Satoshi Akiba" @default.
- Q93045695 P304 "1155-1162" @default.
- Q93045695 P31 Q13442814 @default.
- Q93045695 P356 "10.1248/YAKUSHI.19-00011-2" @default.
- Q93045695 P433 "9" @default.
- Q93045695 P478 "139" @default.
- Q93045695 P577 "2019-01-01T00:00:00Z" @default.
- Q93045695 P698 "31474631" @default.